-
公开(公告)号:US11965201B2
公开(公告)日:2024-04-23
申请号:US17203617
申请日:2021-03-16
申请人: LanzaTech NZ, Inc.
发明人: Kaspar Valgepea , Michael Koepke , James Bruce Yarnton Haycock Behrendorff , Esteban Marcellin , Lars K. Nielsen , Renato de S. P. Lemgruber
IPC分类号: C12P7/56 , C12N1/20 , C12N1/38 , C12N9/06 , C12N9/10 , C12N9/12 , C12N9/78 , C12N9/90 , C12N15/52 , C12P7/04 , C12P7/06 , C12P7/18 , C12P7/40 , C12P7/54
CPC分类号: C12P7/56 , C12N1/20 , C12N1/38 , C12N9/0016 , C12N9/1018 , C12N9/1029 , C12N9/1217 , C12N9/78 , C12N9/90 , C12N15/52 , C12P7/04 , C12P7/065 , C12P7/18 , C12P7/40 , C12P7/54 , C12Y104/01012 , C12Y201/03003 , C12Y207/02002 , C12Y305/03006 , C12Y501/01012 , C12Y504/03005 , Y02E50/10
摘要: The invention provides methods for improving efficiency of fermentation by arginine supplementation, and genetically modified bacterium for use therefor. More particularly the invention provides methods for (i) increasing the production ATP intensive products with arginine supplementation, (ii) increasing utilization of arginine by a C1-fixing bacterium; and (iii) providing C1-fixing bacterium with optimized arginine de-aminase pathways.
-
公开(公告)号:US20170159083A1
公开(公告)日:2017-06-08
申请号:US15368521
申请日:2016-12-02
发明人: Kaspar Valgepea , Michael Koepke , James Bruce Yarnton Haycock Behrendorff , Esteban Marcellin , Lars K. Nielsen , Renato de S.P. Lemgruber
IPC分类号: C12P7/56 , C12P7/54 , C12P7/06 , C12P7/18 , C12N1/20 , C12N9/12 , C12N9/90 , C12N9/06 , C12N1/38 , C12N9/78 , C12N9/10
CPC分类号: C12P7/56 , C12N1/20 , C12N1/38 , C12N9/0016 , C12N9/1018 , C12N9/1029 , C12N9/1217 , C12N9/78 , C12N9/90 , C12N15/52 , C12P7/04 , C12P7/065 , C12P7/18 , C12P7/40 , C12P7/54 , C12Y104/01012 , C12Y201/03003 , C12Y207/02002 , C12Y305/03006 , C12Y501/01012 , C12Y504/03005 , Y02E50/17
摘要: The invention provides methods for improving efficiency of fermentation by arginine supplementation, and genetically modified bacterium for use therefor. More particularly the invention provides methods for (i) increasing the production ATP intensive products with arginine supplementation, (ii) increasing utilization of arginine by a C1-fixing bacterium; and (iii) providing C1-fixing bacterium with optimized arginine de-aminase pathways.
-